IBD Medication Guide

Brand Name(s)

Cimzia®

Drug Class

Biologics

How taken

Injection under the skin (subcutaneous)

Used for

Moderate-to-severe Crohn’s disease

Recommendations for Pregnancy

Low risk

Recommendations for Lactation

Limited human data: probably compatible

Medication indication

Cimzia® is indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy. NOTE: If this medication is recommended for another use than listed, be sure to talk to your doctor about any potential risks and side effects.

Indicated for pediatric use

NOTE:If this medication is recommended for use in children, talk to your doctor about potential risks and side effects.

Most common side effects

Swelling, weight gain, rash, upper respiratory tract infection, urinary tract infection, and joint pain

Other

There have been reports of serious infections associated with certolizumab pegol, including tuberculosis (TB) and other infections such as viruses, fungi, and other bacteria that have spread throughout the body. On rare occasions certain types of cancer, including lymphoma, have been reported.

To see the full prescribing information for this medication, click here.